Characterizing Hospital Admissions in Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada
Objective: Characterizing province-wide hospital admissions in persons with Parkinson’s disease (PD) to inform future healthcare improvement in this population. Background: Persons with PD have longer…Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson’s disease?
Objective: To assess whether 1) tremor and dyskinesia affect photoplethysmography (PPG) data quality, and 2) heart rate (HR) analysis based on continuous PPG can be…Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results
Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease
Objective: To illustrate a successful stepwise dual target MRI guided focused ultrasound ablation in a patient with advanced Parkinson's disease (PD). Background: MR-guided focused ultrasound…Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS
Objective: The Parkinson Associated Risk syndrome (PARS) study is designed to identify a Parkinson disease (PD) biomarker/clinical marker derived cohort enriched to develop typical symptoms…Development of an Item Bank for Assessing Psychosis in Parkinson’s Disease: A Systematic Review
Objective: This study aimed to develop an item bank for assessing psychosis in Parkinson's disease (PD). Background: Psychosis is a common and debilitating symptom in…Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham
Objective: Assess usefulness of low vision occupational therapy (OT) in a small cohort of Parkinson’s disease (PD) patients. Background: PD patients report vision-related symptoms more…Enhanced sensitivity to bradykinesia progression using digital health technologies in early Parkinson’s disease
Objective: To evaluate the sensitivity of digital biomarkers of bradykinesia to longitudinal progression relative to MDS-UPDRS sub-scores in early-stage Parkinson’s disease (PD). Background: It is…modulation of sodium potassium ATPase activity by norepinepherine and serotonin to find an effective cure of parkinson’s disease by introducing the novel concept of insilico drug repurposing
Objective: Parkinson's disease can cause neuropsychiatric disturbances which can range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought. In addition to…Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation.
Objective: To characterize reported infusion site infection adverse events (AEs) and their clinical management in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDP/CDP). Background:…
- « Previous Page
- 1
- …
- 256
- 257
- 258
- 259
- 260
- …
- 436
- Next Page »